NOVATO, Calif. — QT Imaging Holdings, Inc. (OTCQB: QTIH), a medical device company focused on advancing breast health through radiation-free imaging technology, announced the appointment of Satrajit Misra as chief commercial officer.
Mr. Misra’s appointment reflects the company’s focus on commercial growth and broader access to its radiation-free, contrast-free, and compression-free breast imaging solutions.
“We are thrilled to welcome Satrajit as our CCO as we advance commercialization and pivot toward a SaaS and biomarker-driven franchise,” said Dr. Raluca Dinu, chief executive officer of QT Imaging. “Satrajit’s deep domain experience in building and scaling state-of-the-art medical imaging franchises, his strong relationships among leading radiology and oncology thought leaders, and his proven success in driving growth and innovation across imaging and MedTech enterprise, will be instrumental as we accelerate adoption of our innovative diagnostic technologies.”
Mr. Misra brings nearly thirty years of leadership experience across radiology, oncology, and molecular imaging. He most recently served as executive senior vice president and chief sales and marketing officer at Canon Medical Systems USA. Before joining Canon in 2012, he served as head of business development and marketing at Philips and director of business management at Siemens Healthcare.
He holds bachelor’s degrees in applied physics from the University of Calcutta, attended the University of Leeds School of Business and Economic Studies, and completed a negotiation program at Harvard Business School.
In his new role at QT Imaging, Mr. Misra will lead commercial expansion and clinical partnerships, with a focus on positioning the company’s technology as a preferred modality for supplemental screening and biomarker-driven precision diagnostics.
“I’m excited to join QTI at this pivotal inflection point as we bring our transformative breast imaging technology to scale and redefine standards in early detection and precision diagnostics,” said Mr. Misra. “While I worked closely with Raluca and her team via the Company’s ongoing strategic partnership with Canon USA, it was captivating to watch the scale, scope and speed with which QTI had already begun to transform breast health management for the potential benefit of millions of patients. I look forward to working with the QTI team to develop and expand the product pipeline, accelerate growth, and enhance value for our shareholders.”
